LONDON--(BUSINESS WIRE)--The global diabetic neuropathy drugs market is expected to post a CAGR of more than 6% during the period 2019-2023, according to the latest market research report by Technavio ...
The rising awareness about diabetic neuropathy is one of the prominent factors likely to contribute to the diabetic neuropathy drugs market growth in the forthcoming years. Several awareness programs ...
SPONSORED — Neuropathy affects an estimated 25 million Americans today, causing pain, numbness, and tingling in the feet, hands, and limbs. While medications like gabapentin are commonly prescribed to ...
CIPN is a common nerve-damaging side effect of chemotherapy with no FDA-approved treatment optionsFast Track designation ...
More than 20 million Americans suffer from peripheral neuropathy — a painful and sometimes debilitating condition that make even the most routine tasks become difficult. Numbness, shooting pain or ...
LONDON--(BUSINESS WIRE)--Several market players in diabetic neuropathy market are increasingly focusing on the development of disease-modifying drugs for the treatment of diabetic neuropathy. The US ...
Sonnet BioTherapeutics has struck a deal to acquire an ex-Serono drug from Relief Therapeutics. The agreement tees Sonnet up to advance the asset in chemotherapy-induced peripheral neuropathy (CIPN) ...
ATX01, a new topical treatment for chemotherapy-induced peripheral neuropathy, will be investigated in a phase 2 trial. Researchers recently initiated a phase 2 clinical trial evaluating ATX01 ...
"Diabetic Neuropathy Clinical Trial"Leading diabetic neuropathy companies include Vertex Pharmaceuticals Incorporated, Novaremed, Trevena, Inc., WinSanTor, Inc ...
A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study's safety review committee (SRC) reviewed the data from ...
DARA BioSciences announced it has submitted an Orphan Drug Application to the FDA for KRN5500, a compound in development to treat painful chronic chemotherapy-induced peripheral neuropathy (CCIPN).
SPONSORED – Neuropathy affects an estimated 25 million Americans today, causing pain, numbness, and tingling in the feet, hands, and limbs. While medications like gabapentin are commonly prescribed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results